Navigation Links
Researcher awarded $1 million for stress-associated disease and aging research
Date:4/20/2012

A scientist from the Florida campus of The Scripps Research Institute has been awarded just over $1 million from the National Institutes of Health to develop a range of new tests that could lead to new treatments for a number of stress-associated and degenerative disorders of advancing age.

Shuji Kishi, an assistant professor at Scripps Research, is the principal investigator for the three-year study.

The new tests will focus on diseases linked to oxidative stress (and the stress-induced inflammation that often accompanies it), closely associated with aging. Those diseases include atherosclerosis, Alzheimer's and Parkinson's disease, diabetes, heart attack, sarcopenia, liver and kidney disease, and stroke.

Despite the widespread damage caused by oxidative stress, the number of therapeutic remedies for it remains virtually non-existent.

During periods of cellular stress, such as exposure to UV radiation or chronic diseases like cancer, the level of highly reactive oxygen-containing molecules in cells can increase, resulting in misfolded proteins and cell damage. Cells can protect themselves from this damage by activating certain antioxidant genes, but age and extended periods of stress can impair that response.

In the new study, Kishi plans to develop a series of tests to identify drug leads that will prevent oxidative damage in a novel vertebrate model. His approach will involve high-content screens in zebrafish.

"The cell-based assays can be pursued using the ultra-high-throughput screening resources available at Scripps Florida, including a chemical library comprised of approximately 1 million compounds with structures that we know have properties suitable for drug development," Kishi said.

Beyond the cell-based tests, Kishi plans to use newly developed transgenic zebrafish as a model organism for testing any drug candidates uncovered during cell-based screening. Those with potential after this round of testing will then be further evaluated to determine organ specificity and developmental toxicity, and for overall efficacy in preventing oxidative damage.

"We want to understand how these selected small molecules work in the zebrafish so that additional drugs can be designed based on the in vivo antioxidant response," Kishi said.

Kishi's laboratory is broadly focused on developing experimental models of aging and geriatric diseases, including neurodegenerative diseases.


'/>"/>

Contact: Mika Ono
mikaono@scripps.edu
858-784-2052
Scripps Research Institute
Source:Eurekalert  

Related biology news :

1. NCEAS researchers offer new ecological model for deep-water oil spills
2. Southampton researchers lead 2 international projects to help people out of poverty
3. Researchers across North America team up to find genetic markers for autism
4. UCSB researchers discover particularly dangerous Salmonella
5. Researchers discover non-surgical test for brain cancer
6. Researchers have identified a gene with a key role in neuronal survival
7. BUSM researchers identify genes that influence hippocampal volume
8. UCSB researchers find a way to detect stealthy, hypervirulent Salmonella strains
9. BUSM researchers identify key regulator of inflammatory response
10. Researchers call for a new direction in oil spill research
11. Researchers identify Achilles heel of dengue virus, target for future vaccines
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Researcher awarded $1 million for stress-associated disease and aging research
(Date:6/22/2016)... , June 22, 2016 On Monday, ... call to industry to share solutions for the Biometric ... U.S. Customs and Border Protection (CBP), explains that CBP ... are departing the United States , ... and to defeat imposters. Logo - ...
(Date:6/20/2016)... , June 20, 2016 Securus ... justice technology solutions for public safety, investigation, corrections ... the prisons involved, it has secured the final ... (DOC) facilities for Managed Access Systems (MAS) installed. ... additional facilities to be installed by October, 2016. ...
(Date:6/15/2016)... June 15, 2016 Transparency ... titled "Gesture Recognition Market by Application Market - Global Industry Analysis ... 2024". According to the report, the  global gesture recognition ... 2015 and is estimated to grow at a ... by 2024.  Increasing application of gesture ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... , June 24, 2016 Epic Sciences ... detects cancers susceptible to PARP inhibitors by targeting ... cells (CTCs). The new test has already been ... in multiple cancer types. Over 230 ... damage response pathways, including PARP, ATM, ATR, DNA-PK ...
(Date:6/24/2016)... ... , ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical ... mesothelioma. Their findings are the subject of a new article on the Surviving Mesothelioma ... in the blood, lung fluid or tissue of mesothelioma patients that can help point ...
(Date:6/23/2016)... ... 23, 2016 , ... UAS LifeSciences, one of the leading ... UP4™ Probiotics, into Target stores nationwide. The company, which has been manufacturing high ... its list of well-respected retailers. This list includes such fine stores as Whole ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
Breaking Biology Technology: